ECSP972046A - PROLONGED RELEASE FORMULA - Google Patents
PROLONGED RELEASE FORMULAInfo
- Publication number
- ECSP972046A ECSP972046A ECSP972046A ECSP972046A EC SP972046 A ECSP972046 A EC SP972046A EC SP972046 A ECSP972046 A EC SP972046A EC SP972046 A ECSP972046 A EC SP972046A
- Authority
- EC
- Ecuador
- Prior art keywords
- prolonged release
- release formula
- prolonged
- nausea
- vomiting
- Prior art date
Links
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 239000007916 tablet composition Substances 0.000 abstract 1
- 229960002416 venlafaxine hydrochloride Drugs 0.000 abstract 1
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con una fórmula posológica y dosis unitaria de la misma, de clorhidrato de venlafaxina, un agente antidepresivo, de liberación prolongada sobre 24 horas, que ofrece un control de las concentraciones plasmáticas mejor que el de las fórmulas convencionales en tabletas que deberán administrarse dos o más veces al día, y que también se asocia con una incidencia más baja de náuseas y vómitos que las tabletas convencionales.The present invention relates to a dosage formula and unit dose thereof, of venlafaxine hydrochloride, an antidepressant agent, prolonged-release over 24 hours, which offers better control of plasma concentrations than conventional tablet formulations than They should be administered two or more times a day, and that is also associated with a lower incidence of nausea and vomiting than conventional tablets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972046 ECSP972046A (en) | 1997-03-04 | 1997-03-04 | PROLONGED RELEASE FORMULA |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972046 ECSP972046A (en) | 1997-03-04 | 1997-03-04 | PROLONGED RELEASE FORMULA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972046A true ECSP972046A (en) | 1998-02-13 |
Family
ID=42042879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972046 ECSP972046A (en) | 1997-03-04 | 1997-03-04 | PROLONGED RELEASE FORMULA |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972046A (en) |
-
1997
- 1997-03-04 EC ECSP972046 patent/ECSP972046A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY24613A1 (en) | CONTROLLED RELEASE FORMULA INCLUDING VENLAFAXINE | |
| AR014012A1 (en) | PROLONGED RELEASE FORM | |
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| RU94032150A (en) | Medicinal agent exhibiting delayed release of active-acting substance | |
| NO20011471D0 (en) | New oral sustained release formulations | |
| ECSP045102A (en) | Pharmaceutical formulation containing 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol and provides a delayed release of the active ingredient | |
| AR002754A1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING MICRO-ENCAPSULATED VIABLE LACTOBACILLUS BACTERIA, AND USE OF THE COMPOSITION TO PREPARE A MEDICINAL PRODUCT | |
| ES2088312T3 (en) | CONTROLLED RELEASE FORMULATION CONTAINING TRAMADOL. | |
| TW200630123A (en) | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form | |
| PT1411921E (en) | Pharmaceutical compositions containing terbinafine and use thereof | |
| AR036312A1 (en) | PHARMACEUTICAL COMPOSITION | |
| DE60320039D1 (en) | TRAMADOL FORMULATIONS WITH DELAYED RELEASE AND 24 HOUR EFFICACY | |
| ATE199495T1 (en) | PHARMACEUTICAL PREPARATION FOR DIRECT COMPRESSION | |
| ECSP972046A (en) | PROLONGED RELEASE FORMULA | |
| ECSP982704A (en) | PROLONGED RELEASE FORMULA | |
| DE60112578D1 (en) | PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE | |
| BR9912260A (en) | Plaster containing a transdermal therapeutic system and a single dose for administration | |
| PE20011042A1 (en) | USE OF GLUTAMINE FOR THE PREVENTION OF LATE ONSET DIARRHEA INDUCED BY IRINOTECAN | |
| SE9700868D0 (en) | calcium composition | |
| TH51486A (en) | Mertasapine's new recipe | |
| ES2082524T3 (en) | DELAYED RELEASE MEDICATION CONTAINING A DERIVATIVE OF DIHYDROPYRIDINE IN THE FORM OF NANOSOL AND ITS PREPARATION. |